Lipocine
LPCN
#10138
Rank
โ‚ฌ17.33 M
Marketcap
3,12ย โ‚ฌ
Share price
16.51%
Change (1 day)
-37.09%
Change (1 year)

Market capitalization of Lipocine (LPCN)

Market cap: โ‚ฌ17.33 Million

As of December 2025 Lipocine has a market cap of โ‚ฌ17.33 Million. This makes Lipocine the world's 10138th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Lipocine from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ17.33 M-29.12%
2024โ‚ฌ24.46 M82.34%
2023โ‚ฌ13.41 M-59.13%
2022โ‚ฌ32.82 M-57.52%
2021โ‚ฌ77.26 M6.39%
2020โ‚ฌ72.62 M461.45%
2019โ‚ฌ12.93 M-47.62%
2018โ‚ฌ24.69 M-59.36%
2017โ‚ฌ60.77 M-4.88%
2016โ‚ฌ63.88 M-70.39%
2015โ‚ฌ0.21 B289.9%
2014โ‚ฌ55.33 M-26.88%
2013โ‚ฌ75.67 M

End of Day market cap according to different sources

On Dec 17th, 2025 the market cap of Lipocine was reported to be:

โ‚ฌ17.33 Million
by Nasdaq info icon info icon
โ‚ฌ17.33 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Seagen
SGEN
โ‚ฌ36.72 B 211,696.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
โ‚ฌ8.52 B 49,081.79%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Agile Therapeutics
AGRX
โ‚ฌ8.87 M-48.83%๐Ÿ‡บ๐Ÿ‡ธ USA